Short answer
Sionna Therapeutics, Inc. (SION) filed an 8-K current report with the SEC on May 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2026 results and business highlights covered the three months ended March 31, 2026.
Sionna Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results and business highlights covered the three months ended March 31, 2026
- Press release issued May 12, 2026 and furnished as Exhibit 99.1
- Investor focus: financial performance and program updates detailed in the accompanying press release
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Sionna Therapeutics, Inc. 8-K filings
Get the next SION 8-K as it lands
Follow SION for push alerts, or ask the research agent what this filing means.